Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei United Pharmaceutical Co., Ltd. is a major pharmaceutical manufacturing entity and a core subsidiary of The United Laboratories (TUL), located in Shijiazhuang, China. The company is a leading global producer of active pharmaceutical ingredients (APIs) and finished dosage forms, with a dominant market position in semi-synthetic penicillins and cephalosporins. Beyond its traditional strength in anti-infectives, the company has successfully diversified into the biopharmaceutical sector, manufacturing human insulin and advanced insulin analogs. Its vertically integrated production model covers the entire value chain from fermentation and chemical synthesis to final clinical products. Hebei United Pharmaceutical operates large-scale, GMP-certified facilities that supply essential medicines to both the Chinese domestic market and international healthcare systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei United Pharmaceutical.